本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Royalty Pharma plc

58.70
+0.23000.39%
成交量:69.77萬
成交額:4,102.45萬
市值:338.66億
市盈率:31.49
高:59.18
開:58.81
低:58.46
收:58.47
52周最高:64.38
52周最低:34.63
股本:5.77億
流通股本:3.93億
量比:0.52
換手率:0.18%
股息:0.91
股息率:1.55%
每股收益(TTM):1.86
每股收益(LYR):1.78
淨資產收益率:13.97%
總資產收益率:5.09%
市淨率:4.96
市盈率(LYR):32.95

資料載入中...

2026/08/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/05

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/05

重要事件披露

Form 8-K - Current report
2026/07/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/04

重要事件披露

Form 8-K - Current report
2026/05/28

重要事件披露

Form 8-K - Current report
2026/05/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/06

重要事件披露

Form 8-K - Current report